Form EFFECT Cingulate Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cingulate receives first U.S. patent for ADHD drug candidate CTx-1301
- Quarterman Realty Group Inc. Announces Expanded Real Estate Education Support for South Jersey Buyers, Sellers, and Relocating Families
- Crypto News Today: AlphaPepe Nears Third CEX Partnership as Ethereum Price Prediction Targets $7,000
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
